Pharmacology

Clinical Insights

Sarolaner Use in Dogs

Sarolaner is an ectoparasiticide that is effective against fleas and ticks on dogs when administered once a month. This article covers its development, mechanism of action, dosage, safety, and efficacy against 6 common species of ectoparasites. It also compares the safety and efficacy of sarolaner with those of 2 other popular ectoparasiticides in the same class: afoxolaner and fluralaner.

Clinical Insights

Oral Cyclosporine Use in Dogs

Cyclosporine is a potent immunosuppressive agent that has treatment applications in both veterinary and human medicine. Oral cyclosporine is currently being used to treat a spectrum of inflammatory and immune-mediated diseases in dogs, including but not limited to atopic dermatitis, autoimmune skin disorders, perianal fistula, inflammatory bowel disease, granulomatous meningoencephalitis, and immune-mediated blood disorders.

Clinical Insights

Oclacitinib: Treating Pruritus and Beyond

For years, glucocorticoids and cyclosporine have been used for the symptomatic management of atopic dermatitis, including the associated pruritus. In the past 5 years, however, oclacitinib (Apoquel; zoetisus.com), a Janus kinase (JAK) inhibitor, has become another important drug in the management of allergic pruritus.

Clinical Insights

Grapiprant for Control of Osteoarthritis Pain in Dogs

For centuries, nonsteroidal anti-inflammatory drugs (NSAIDs) have been used for pain control. However, their use has been associated with potentially life-threatening adverse drug events. Grapiprant is a novel drug for treatment of osteoarthritic pain in dogs. Approved in 2016, it is a non-cyclooxygenase (COX)-inhibiting NSAID.

motion sickness

How to Educate Clients About Motion Sickness in Dogs

Motion sickness can afflict any pet during even the shortest of rides. Read more about how to educate clients about the symptoms and treatments for motion sickness with advice from Zoetis Veterinary Medical Lead, Dr. Joyce Login, DVM.

Clinical Insights

Alfaxalone: An Old Drug in a New Formulation

Alfaxalone has been used to induce general anesthesia for many years, but only recently has a new formulation with preservatives become available in the United States. This formulation has a shelf life of 28 days after first use. It is approved for IV administration to induce and maintain general anesthesia in dogs and cats; however, it is also used via the IM route for induction and sedation (off label).

DMCA.com Protection Status
[2
[2
2]
2]
MENU